Related Experiment Video
Updated: Nov 9, 2025

10:13
A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
11.4K
Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior
Zaizai Dong1, Shi Yan2, Bing Liu2
1Beijing Advanced Innovation Center for Biomedical Engineering, School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China.
Nano Letters
|April 8, 2021
Summary
This study introduces a novel nanoplatform for analyzing gene properties and drug resistance in millions of single living cancer cells. The platform reveals a direct correlation between genetic mutations and drug susceptibility, advancing precision medicine.
Area of Science:
- Biotechnology
- Molecular Biology
- Cancer Research
Background:
- Genetic heterogeneity in cancer complicates precise drug treatment.
- Current single-cell gene analysis methods often destroy cells, limiting correlation with real-time behavior.
- Developing methods to link genetic profiles with cellular responses in living cells is crucial.
Purpose of the Study:
- To develop a high-throughput nanoplatform for analyzing gene properties and drug resistance in millions of single living cancer cells.
- To overcome the limitations of cell lysis in current single-cell analysis methods.
- To investigate the relationship between intracellular genetic properties and real-time cellular behaviors.
Main Methods:
- Designed a 'Domino-probe' for amplified fluorescence signal detection of intracellular target RNAs.
- Developed an on-chip addressable microwell-nanopore array for efficient probe delivery and cell observation.
- Utilized the nanoplatform for analyzing primary lung cancer cell samples.
Main Results:
- The nanoplatform successfully interrogated gene properties and drug resistance in millions of single cells.
- Demonstrated enhanced electro-delivery of the Domino-probe and in situ observation of cell behaviors.
- Validated a positive correlation between the ratio of EGFR mutant cells and their drug susceptibilities in lung cancer samples.
Conclusions:
- The developed nanoplatform enables high-throughput, precise analysis of single living cells.
- This technology facilitates the exploration of genotype-phenotype relationships at the single-cell level.
- The platform holds significant potential for advancing cancer research and personalized drug development.

